Helicos BioSciences Corporation Settles its Patent Litigation Against Pacific Biosciences

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Helicos BioSciences Corporation (OTCQB: HLCS.PK) announced today that it has settled its patent infringement litigation against Pacific Biosciences, Inc. The settlement gives Pacific Biosciences freedom-to-operate from Helicos’s patents within a limited field of use covering Pacific Biosciences’ current products only. In addition to paying an undisclosed financial settlement, Pacific Biosciences agreed to refrain from challenging the validity, enforceability, or patentability of any of Helicos’s patents, which includes halting its efforts in the inter partes reexamination of the patents in suit with the USPTO.